Microphage Inc. Wins R&D Magazine 100 Award’ For World’s First Test Designed To Rapidly Identify Bacterial Infections And Antibiotic Susceptibility

LONGMONT, Colo.--(BUSINESS WIRE)--MicroPhage announced today that it has received the ‘R&D Magazine 100 Award’ in Bioscience for its ‘Microphage MRSA/MSSA Blood Culture Test.’ The first of MicroPhage’s instrument-free, rapid tests is based on the Company’s patented Bacteriophage Amplification platform technology.